- INSY has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $23.7 million.
- INSY has traded 180,379 shares today.
- INSY is down 3.2% today.
- INSY was up 5.8% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in INSY with the Ticky from Trade-Ideas. See the FREE profile for INSY NOW at Trade-Ideas More details on INSY: Insys Therapeutics, Inc., a commercial-stage specialty pharmaceutical company, develops and commercializes supportive care products. It focuses on utilizing its proprietary formulation technologies to address the clinical shortcomings of existing commercial pharmaceutical products. INSY has a PE ratio of 21.1. Currently there are 2 analysts that rate Insys Therapeutics a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Insys Therapeutics has been 543,600 shares per day over the past 30 days. Insys has a market cap of $1.2 billion and is part of the health care sector and drugs industry. Shares are up 42.5% year-to-date as of the close of trading on Monday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.